Literature DB >> 23677791

Human papillomavirus type 16 viral load measurement as a predictor of infection clearance.

Andrea Trevisan1,2, Nicolas F Schlecht3, Agnihotram V Ramanakumar4, Luisa L Villa5,6,2, Eduardo L Franco4.   

Abstract

Viral load measurements may predict whether human papillomavirus (HPV) type 16 infections may become persistent and eventually lead to cervical lesions. Today, multiple PCR methods exist to estimate viral load. We tested three protocols to investigate viral load as a predictor of HPV clearance. We measured viral load in 418 HPV16-positive cervical smears from 224 women participating in the Ludwig-McGill Cohort Study by low-stringency PCR (LS-PCR) using consensus L1 primers targeting over 40 known HPV types, and quantitative real-time PCR (qRT-PCR) targeting the HPV16 E6 and L1 genes. HPV16 clearance was determined by MY09/11 and PGMY PCR testing on repeated smears collected over 5 years. Correlation between viral load measurements by qRT-PCR (E6 versus L1) was excellent (Spearman's rank correlation, ρ = 0.88), but decreased for L1 qRT-PCR versus LS-PCR (ρ = 0.61). Viral load by LS-PCR was higher for HPV16 and related types independently of other concurrent HPV infections. Median duration of infection was longer for smears with high copy number by all three PCR protocols (log rank P<0.05). Viral load is inversely related to HPV16 clearance independently of concurrent HPV infections and PCR protocol.

Entities:  

Mesh:

Year:  2013        PMID: 23677791      PMCID: PMC4093775          DOI: 10.1099/vir.0.051722-0

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  Human Papillomavirus Viral Load and Transmission in Young, Recently Formed Heterosexual Couples.

Authors:  Michel D Wissing; Karolina Louvanto; Emilie Comète; Ann N Burchell; Mariam El-Zein; Allita Rodrigues; Pierre-Paul Tellier; François Coutlée; Eduardo L Franco
Journal:  J Infect Dis       Date:  2019-08-30       Impact factor: 5.226

2.  Changes in DNA Level of Oncogenic Human Papillomaviruses Other Than Types 16 and 18 in Relation to Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.

Authors:  Long Fu Xi; Mark Schiffman; James P Hughes; Denise A Galloway; Laura A Koutsky; Nancy B Kiviat
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-05-17       Impact factor: 4.254

3.  Association of Human Papillomavirus 31 DNA Load with Risk of Cervical Intraepithelial Neoplasia Grades 2 and 3.

Authors:  Xia Liu; Mark Schiffman; Ayaka Hulbert; Zhonghu He; Zhenping Shen; Laura A Koutsky; Long Fu Xi
Journal:  J Clin Microbiol       Date:  2015-08-19       Impact factor: 5.948

4.  Vaccination of Young Women Decreases Human Papillomavirus Transmission in Heterosexual Couples: Findings from the HITCH Cohort Study.

Authors:  Michel D Wissing; Ann N Burchell; Mariam El-Zein; Pierre-Paul Tellier; François Coutlée; Eduardo L Franco
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-09-05       Impact factor: 4.254

5.  Type-dependent association between risk of cervical intraepithelial neoplasia and viral load of oncogenic human papillomavirus types other than types 16 and 18.

Authors:  Long Fu Xi; Mark Schiffman; Yang Ke; James P Hughes; Denise A Galloway; Zhonghu He; Ayaka Hulbert; Rachel L Winer; Laura A Koutsky; Nancy B Kiviat
Journal:  Int J Cancer       Date:  2017-01-24       Impact factor: 7.396

6.  Reply.

Authors:  Eduardo L Franco; Mariam El-Zein
Journal:  J Infect Dis       Date:  2022-03-02       Impact factor: 7.759

7.  High HPV16 E6 viral load in the oral cavity is associated with an increased number of bacteria: A preliminary study.

Authors:  Hideo Shigeishi; Masaru Sugiyama; Kouji Ohta; Sho Yokoyama; Miyuki Sakuma; Hiroshi Murozumi; Hiroki Kato; Masaaki Takechi
Journal:  Biomed Rep       Date:  2017-11-29

8.  High-risk oral human papillomavirus load in the US population, National Health and Nutrition Examination Survey 2009-2010.

Authors:  Anil K Chaturvedi; Barry I Graubard; Robert K L Pickard; Weihong Xiao; Maura L Gillison
Journal:  J Infect Dis       Date:  2014-03-12       Impact factor: 5.226

9.  Human papillomavirus genotype prevalence in the women of Shanghai, China and its association with the severity of cervical neoplasia.

Authors:  Jingbo Wu; Xiaojing Li; Xiuping Liu; Zuhua Gao
Journal:  Int J Clin Exp Pathol       Date:  2018-09-01

10.  Results of phase 2 trials exploring the safety and efficacy of omiganan in patients with human papillomavirus-induced genital lesions.

Authors:  Melanie Rijsbergen; Rianne Rijneveld; Marina Todd; Gary L Feiss; Stijn T P Kouwenhoven; Koen D Quint; Dirk C J G van Alewijk; Maurits N C de Koning; Erica S Klaassen; Jacobus Burggraaf; Robert Rissmann; Mariëtte I E van Poelgeest
Journal:  Br J Clin Pharmacol       Date:  2020-09-28       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.